Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity

With growing competition, Pharma companies are under increased pressure to deliver additional value for key stakeholders through their portfolios. Companies with comprehensive portfolios offering more to physicians, patients, payers and pharmacists will have the competitive edge.

Achieving a balanced portfolio in terms of new product development, lifecycle management and business development and licensing is key to reducing risk and growing franchise sales. With patent expiry of key blockbuster drugs approaching lifecycle management is very popular but over reliance on this approach can damage long-term prospects.
Niche and specialty therapies are gaining ground over primary care portfolios, but growing competition and a tougher pricing and reimbursement environment do not make this an easy direction to follow.
Payers have greater power than ever, and are increasingly influencing physicians' treatment choices. Therefore, pricing and reimbursement analysis needs to be incorporated into portfolio revision process as early as possible in drug development.

Read more...

• Marketing & Branding Excellence (23/06/2010)
• Project & Portfolio Management (23/06/2010)
• Private Health Insurance (11/06/2010)

• Licesing to Win (24/02/2009)
• Infectious Diseases Vaccine Market Overview (19/02/2009)
• Croatia - Pharmaceuticals and Biotechnology (18/10/2008)
• Leading Drug Delivery Companies and Technologies (14/10/2008)
• Management of Diabetes (14/10/2008)
• Obesity Drug Markets (14/10/2008)
• Valuing Pharmaceutical Innovation (14/10/2008)
• The Anti-Infectives Market Outlook to 2013 (14/10/2008)
• Respiratory Disorders (14/10/2008)

---